Synthomer

From Wikipedia, the free encyclopedia
Synthomer plc
TypePublic
LSE: SYNT
IndustryChemicals
Founded1863
HeadquartersLondon, England
Key people
Neil Johnson (Chairman)
Calum MacLean (CEO)
RevenueIncrease £1,644.2 million (2020)[1]
Increase £189.6 million (2020)[1]
Decrease £(1.5) million (2020)[1]
Number of employees
4,750 (2021)[2]
Websitewww.synthomer.com

Synthomer plc (LSE: SYNT), formerly known as Yule Catto & Co, is a British-based chemicals business. It is a constituent of the FTSE 250 Index.

History[]

The company traces its roots back to 1863, when Andrew Yule founded a trading house known as Andrew Yule & Co. in Calcutta.[3] At the same time Andrew's brother, George Yule, set up George Yule & Co. in London, which acted as British agency arm of Andrew Yule & Co.[4]

When in 1919 Andrew Yule & Co. and George Yule & Co. were sold to the US banking group J.P. Morgan & Co. and its British merchant banking affiliate Morgan Grenfell & Co., both were turned from a partnership into a private limited company.[5] That same year Thomas Catto (1879–1959) was sent to India to take over the management of the firm from Sir David Yule (1858–1928), a nephew of Andrew Yule.[6] David Yule continued to hold the title of Chairman but had no active part in the operations of the business.[6]

In 1920 Thomas Catto and David Yule changed the name of the British purchasing arm of Andrew Yule & Co., George Yule and Company, to Yule, Catto & Company Ltd.[7] Due to increased taxation, the devaluation of the Indian rupee and the abolition of the managing agency system, Yule, Catto & Co decided in 1969 to sell its shareholding in Andrew Yule & Co. to the Indian government.[8]

With the acquisition of Revertex Chemicals in 1980,[7] Thomas Catto's son, Stephen (1923–2001) started to turn Yule Catto & Co. into an international speciality chemicals and building products manufacturer.[9] Since 2007 the group has been transformed from a diversified chemical business to a focussed speciality polymer business. In 2012 the company changed its name to Synthomer on the basis that the majority of its business already traded under that name.[10]

In July 2019, Synthomer announced that it was going to buy OMNOVA Solutions for an enterprise value of $824 million;[11] the transaction was completed on 2 April 2020.[12]

Operations[]

The company has three activities: polymer chemicals, pharma chemicals and impact chemicals.[3]

References[]

  1. ^ Jump up to: a b c "Annual Results 2020". Synthomer. Retrieved 4 March 2021.
  2. ^ "Our business". Retrieved 3 March 2021.
  3. ^ Jump up to: a b "Yule Catto - Company Structure Information from ICIS". icis.com. Retrieved 3 April 2015.
  4. ^ Yule, Catto & Co AIM 25
  5. ^ Jones, p.96
  6. ^ Jump up to: a b "Yule Newsletter - Issue 23". yulefamily.com. Retrieved 3 April 2015.
  7. ^ Jump up to: a b Jones, p.325
  8. ^ Jones, p. 297
  9. ^ Obituary: Lord Catto Daily Telegraph, 6 September 2001
  10. ^ Interim Management Statement of Yule Catto & Co Plc for the period 1 July to 8 November 2012
  11. ^ Reuters Staff (July 3, 2019). "Synthomer to buy Omnova in $824 million deal" – via www.reuters.com.
  12. ^ "Synthomer completes acquisition of Omnova". Rubber & Plastics News. April 3, 2020.

Sources[]

  • Jones, Geoffrey (2007). Merchants to Multinationals. Oxford University Press. ISBN 978-0-19-829450-4.

External links[]

Retrieved from ""